銅 ((II) は,パーキンソン病のタンパク質であるアルファ-シヌクレインに結合する
Jennifer C Lee1, Harry B Gray, Jay R Winkler
1Laboratory of Molecular Biophysics, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892-8013, USA. leej4@mail.nih.gov
Journal of the American Chemical Society
|May 10, 2008
まとめ
銅 (II) イオンは,パーキンソン病に関連するタンパク質であるアルファ-シヌクレインに強く結合します. この相互作用は,タンパク質のN端近くで発生し,位置50のヒスティジンを含まない.
科学分野:
- バイオケミストリー バイオケミストリー
- 神経科学は神経科学である.
- タンパク質化学 タンパク質化学
背景:
- アルファシヌクレインは,パーキンソン病に関連するタンパク質です.
- タンパク質と金属の相互作用を理解することは,神経変性疾患の研究において極めて重要です.
研究 の 目的:
- 銅 (II) とアルファ-シヌクレインの相互作用を調査する.
- 結合部位と銅 (II) とアルファ-シヌクレインの親和性を特定する.
主な方法:
- トリプトファンの光強度と崩壊運動の測定.
- サイト・ダイレクト・ミュータジェネシス (F4WとF4W/H50S変異体).
主要な成果:
- 銅 (II) はアルファ-シヌクレインと相互作用し,光変化によって確認されています.
- Cu(II) (Kd = 100 nM) の高親和結合は,pH 7でN端の近くに行われる.
- 位置50のヒスティジンは,高親和性銅結合部位には関与していない.
結論:
- 銅 (II) は,N端の近くにあるアルファシヌクレインに特異的に結合する.
- この結合は50位でのヒスティジンとは独立している.
- この発見は,パーキンソン病の病原性におけるアルファ-シヌクレインの役割を理解するのに役立つ.
関連する概念動画
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...


